skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: SpringerLink Journals - AutoHoldings remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience

Glassman, Danielle C ; Palmaira, Randze L ; Covington, Christina M ; Desai, Avni M ; Ku, Geoffrey Y ; Li, Jia ; Harding, James J ; Varghese, Anna M ; O'Reilly, Eileen M ; Yu, Kenneth H

BMC cancer, 2018-06, Vol.18 (1), p.693-693, Article 693 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
2
Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study

Park, Se Jun ; Kim, Hyunho ; Shin, Kabsoo ; Hong, Tae Ho ; Suh, Ja Hee ; Lee, Myung Ah

BMC cancer, 2021-11, Vol.21 (1), p.1176-1176, Article 1176 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study

Perkhofer, L ; Berger, A W ; Beutel, A K ; Gallmeier, E ; Angermeier, S ; Fischer von Weikersthal, L ; Goetze, T O ; Muche, R ; Seufferlein, T ; Ettrich, T J

BMC cancer, 2019-10, Vol.19 (1), p.990-990, Article 990 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients

Hamaguchi, Tetsuya ; Tsuji, Akihito ; Yamaguchi, Kensei ; Takeda, Koji ; Uetake, Hiroyuki ; Esaki, Taito ; Amagai, Kenji ; Sakai, Daisuke ; Baba, Hideo ; Kimura, Masami ; Matsumura, Yasuhiro ; Tsukamoto, Tetsuji

Cancer chemotherapy and pharmacology, 2018-12, Vol.82 (6), p.1021-1029 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
5
Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting
Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting
Material Type:
Artigo 		Adicionar ao Meu Espaço

Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting

Liang, Barry J ; Pigula, Michael ; Baglo, Yan ; Najafali, Daniel ; Hasan, Tayyaba ; Huang, Huang-Chiao

Journal of nanobiotechnology, 2020-01, Vol.18 (1), p.1-14, Article 1 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
Phase I study of liposomal irinotecan (LY01610) in patients with advanced esophageal squamous cell carcinoma
Phase I study of liposomal irinotecan (LY01610) in patients with advanced esophageal squamous cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I study of liposomal irinotecan (LY01610) in patients with advanced esophageal squamous cell carcinoma

Liu, Yun ; Zhang, Bo ; Xu, Jianping ; Wang, Xingyuan ; Tang, Jialin ; Huang, Jing

Cancer chemotherapy and pharmacology, 2021-09, Vol.88 (3), p.403-414 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
7
MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids
MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids
Material Type:
Artigo 		Adicionar ao Meu Espaço

MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids

Liu, Xin ; Flinders, Colin ; Mumenthaler, Shannon M. ; Hummon, Amanda B.

Journal of the American Society for Mass Spectrometry, 2018-03, Vol.29 (3), p.516-526 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
8
Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure
Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Minimal contribution of the hepatic uptake transporter OATP1B1 to the inter-individual variability in SN-38 pharmacokinetics in cancer patients without severe renal failure

Tsuboya, Ayako ; Kubota, Yutaro ; Ishida, Hiroo ; Ohkuma, Ryotaro ; Ishiguro, Tomoyuki ; Hirasawa, Yuya ; Ariizumi, Hirotsugu ; Tsunoda, Takuya ; Sasaki, Yasutsuna ; Matsumoto, Natsumi ; Kondo, Yusuke ; Tomoda, Yukana ; Kusuhara, Hiroyuki ; Fujita, Ken-ichi

Cancer chemotherapy and pharmacology, 2021-09, Vol.88 (3), p.543-553 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
9
Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors
Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors

Sathe, Abhishek G. ; Singh, Indrajeet ; Singh, Pratap ; Diderichsen, Paul M. ; Wang, Xiaohui ; Chang, Peter ; Taqui, Atiya ; Phan, See ; Girish, Sandhya ; Othman, Ahmed A.

Clinical pharmacokinetics, 2024-05, Vol.63 (5), p.669-681 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
10
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin

Kawakami, Takeshi ; Todaka, Akiko ; Oshima, Kotoe ; Fushiki, Kunihiro ; Hamauchi, Satoshi ; Tsushima, Takahiro ; Yokota, Tomoya ; Onozawa, Yusuke ; Yasui, Hirofumi ; Yamazaki, Kentaro

BMC cancer, 2023-01, Vol.23 (1), p.68-8, Article 68 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1.118)

Data de Publicação 

De até
Refinar
  1. Antes de1997  (16)
  2. 1997Até2002  (66)
  3. 2003Até2008  (152)
  4. 2009Até2015  (316)
  5. Após 2015  (578)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.112)
  2. Japonês  (146)
  3. Alemão  (8)
  4. Francês  (7)
  5. Chinês  (3)
  6. Norueguês  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.